Increased cytoplasmic expression of DLL4 is associated with favorable prognosis in colorectal cancer

被引:3
|
作者
Naseri, Marzieh [1 ,2 ]
Zanjani, Leili Saeednejad [1 ]
Vafaei, Somayeh [1 ,2 ]
Gheytanchi, Elmira [1 ]
Abolhasani, Maryam [1 ,3 ,4 ]
Bozorgmehr, Mahmood [1 ]
Pirmardan, Ehsan Ranaei [5 ]
Ghods, Roya [1 ,2 ]
Madjd, Zahra [1 ,2 ,4 ]
机构
[1] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran 1449614530, Iran
[2] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran 1449614530, Iran
[3] Iran Univ Med Sci, Hasheminejad Kidney Ctr, Tehran 1449614535, Iran
[4] Iran Univ Med Sci, Dept Pathol, Tehran 1449614530, Iran
[5] Harvard Med Sch, Mol Biomarkers Nanoimaging Lab, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
colorectal cancer; DLL4; distant metastasis; overall survival; tissue microarray; tumor recurrence; ENDOTHELIAL GROWTH-FACTOR; INHIBITS TUMOR-GROWTH; COLON-CANCER; ANGIOGENESIS; BLOCKADE; PREDICTS; TARGET; MOUSE; VEGF;
D O I
10.2217/fon-2020-0840
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: DLL4 of the Notch pathway is a key regulator of VEGF expression, which mediates tumor neovascularization and stem cell self-renewal in colorectal cancer (CRC). The authors investigated the association of DLL4 expression with the clinicopathological characteristics and survival outcomes of CRC patients. Methods: DLL4 expression level was evaluated in 199 CRC samples using immunohistochemistry analysis of tissue microarrays. Results: The high expression of DLL4 was inversely associated with distant metastasis (p < 0.029), tumor recurrence (p < 0.04) and longer overall survival following curative surgery compared with those with low DLL4 expression with 95% CI (log-rank test: p = 0.050). In univariate analysis, histological grade (hazard ratio: 3.859; 95% CI: 1.081-13.784; p = 0.038) was a strong prognostic risk factor, affecting the overall survival of CRC patients. Conclusion: The authors' results demonstrate that DLL4 expression might be considered a favorable prognostic factor for overall survival in CRC patients.
引用
收藏
页码:3231 / 3242
页数:12
相关论文
共 50 条
  • [1] Clinical implications of DLL4 expression in gastric cancer
    Sumiya Ishigami
    Takaaki Arigami
    Yoshikazu Uenosono
    Hiroshi Okumura
    Hiroshi Kurahara
    Yasuto Uchikado
    Tetsuro Setoyama
    Yoshiaki Kita
    Yuko Kijima
    Yuka Nishizono
    Akihiro Nakajo
    Tetsuro Owaki
    Shinichi Ueno
    Shoji Natsugoe
    Journal of Experimental & Clinical Cancer Research, 32
  • [2] Clinical implications of DLL4 expression in gastric cancer
    Ishigami, Sumiya
    Arigami, Takaaki
    Uenosono, Yoshikazu
    Okumura, Hiroshi
    Kurahara, Hiroshi
    Uchikado, Yasuto
    Setoyama, Tetsuro
    Kita, Yoshiaki
    Kijima, Yuko
    Nishizono, Yuka
    Nakajo, Akihiro
    Owaki, Tetsuro
    Ueno, Shinichi
    Natsugoe, Shoji
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [3] Low HES-1 and positive DLL4 expression predicts poor prognosis of colorectal cancers
    Kim, Gilhyang
    Jung, Jiyoon
    Kim, Jeong Won
    Kim, Joo Young
    PATHOLOGY, 2023, 55 (01) : 52 - 57
  • [4] VGLL4 with Low YAP Expression is Associated with Favorable Prognosis in Colorectal Cancer
    Kim, Joo Young
    Kim, Eun Kyung
    Lee, Won Mi
    Hong, Young Ok
    Lee, Hojung
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 695 - 696
  • [5] VGLL4 with Low YAP Expression is Associated with Favorable Prognosis in Colorectal Cancer
    Kim, Joo Young
    Kim, Eun Kyung
    Lee, Won Mi
    Hong, Young Ok
    Lee, Hojung
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 695 - 696
  • [6] VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer
    Kim, Joo Young
    Kim, Eun Kyung
    Lee, Won Mi
    Hong, Young Ok
    Lee, Hojung
    APMIS, 2020, 128 (10) : 543 - 551
  • [7] Notch and Delta-like 4 ligand (DLL4) expression in bevacizumabtreated colorectal cancer patients
    Negri, F. V.
    Bozzetti, C.
    Crafa, P.
    Lagrasta, C.
    Pedrazzi, G.
    Gardini, G.
    Tamagnini, I.
    Porzio, R.
    Tomasello, G.
    Ardizzoni, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S565 - S565
  • [8] ANALYSIS OF THE RELATIONSHIP BETWEEN MIR-195 TARGETING DLL4 EXPRESSION IN COLORECTAL CANCER
    Li, Guosheng
    Huang, Fei
    Yang, Yunhong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 : 29 - 29
  • [9] Prognostic significance of DLL4 expression in papillary thyroid cancer
    Zhang, Y. -Z.
    Qin, F.
    Han, Z. -G.
    Liu, Q.
    Zhou, L.
    Wang, Y. -W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (15) : 2901 - 2905
  • [10] NOTCH AND DLL4 EXPRESSION IN COLON CANCER PATIENTS TREATED WITH BEVACIZUMAB
    Negri, Francesca V.
    Bozzetti, Cecilia
    Lagrasta, Costanza
    Crafa, Pellegrino
    Cavalli, Stefano
    Pedrazzi, Giuseppe
    Porzio, Rosa
    Bacchini, Gianpaolo
    Cavanna, Luigi
    Paties, Carlo
    Ardizzoni, Andrea
    ANNALS OF ONCOLOGY, 2012, 23 : 107 - 108